ACAT prowls, MSFT big trader, MRNA sinks

Arctic Cat Inc. (Nasdaq: ACAT) shares improved 15.3 percent Thursday to $15.82. Volume was 224,068 shares, better than double its daily average, on quarterly revenues of $152 million, beating estimates of $136.8 million.

Microsoft Corporation (Nasdaq: MSFT) traded in 22.7 million shares Thursday, building toward a daily average of 58.3 million. Share prices stepped down 0.6 percent to $28.61

Marina Biotech Inc. (Nasdaq: MRNA) shares let go of 9.1 percent to $1.09 Thursday, on volume of 580,004 shares, beating its daily average of 234,217, on Japanese patent news concerning one of its nucleic acid products.

Tags: ACAT, biopharmaceuticals, Biotech Stocks, buzz stocks, consumer discretionary, healthcare, MRNA, msft, nasdaq

This entry was posted on Thursday, January 27th, 2011 at 11:29 am by Glenn and is filed under Consumer Discretionary Stocks, Health Care Stocks, Technology Stocks. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.